Cellin Technologies

No new round recorded in 191 months.

1. 05 Nov 2010

   Seed

   €352K

   Cumulative €352K

Amounts in EUR, converted at the ECB rate on the event date. Funding totals exclude debt, grants and state aid; rounds whose instrument is not yet established are still counted. Every figure links to its source.

• Launch09 Jun 2026

  Cellin Technologies is advancing a cell-therapy treatment that stimulates the body to grow new blood vessels, helping patients avoid amputation.

  ▸Source: pmo.ee

  “For decades, physicians have battled vascular calcification, but there comes a point when even the most advanced treatments are no longer effective. That is when an idea that sounds almost like…”

  Read at pmo.ee

• Funding05 Nov 2010EUR 352K

  Cellin Technologies received a seed investment of about EUR 352,000 from the Estonian Development Fund and an unnamed co-investor to support stem cell research, together acquiring a one-third stake in the company. This is a historical round from November 2010 that predates the company's tracked events.

  ▸Source: baltic-course.com

  Read at baltic-course.com

• Dr. Andrus Loog

  Chairman of the Supervisory Board

• Dr. Ivar Järving

  Responsible Person on GMP

Raised €352K to date · FY2024 turnover €4K · 6 employees

• Turnover grew 65% FY2023→FY2024.
• Headcount 5 → 6 over FY2022→FY2023.

What does Cellin Technologies do?

Company advancing cell-therapy treatment

When was Cellin Technologies founded?

Cellin Technologies was founded in 2008.

Where is Cellin Technologies headquartered?

Cellin Technologies is based in Estonia.

How much funding has Cellin Technologies raised?

Cellin Technologies has raised €352K (across 1 round · last 05 Nov 2010).

What was Cellin Technologies's latest funding round?

Cellin Technologies's most recent disclosed round was a seed round of €352K, announced 5 November 2010.

What is Cellin Technologies's revenue?

Cellin Technologies reported €4K in turnover for FY2024, per official registry filings.